
Not actual size
(15 mm x 8 mm)What is BIKTARVY?
BIKTARVY is a complete HIV-1 treatment that combines 3 powerful medicines into 1 small pill, taken once a day with or without food.
BIKTARVY should not be taken with other HIV-1 medicines.
During this time, Gilead is committed to helping those living with HIV have access to their medications. If you need support affording your medicine, we may be able to help. Get Financial Support
Not actual size
(15 mm x 8 mm)BIKTARVY is a complete HIV-1 treatment that combines 3 powerful medicines into 1 small pill, taken once a day with or without food.
BIKTARVY should not be taken with other HIV-1 medicines.
BIKTARVY is a prescription medicine for adults and children with HIV-1 who weigh at least 55 lbs and are either:
*For adults and children replacing their current regimen, their healthcare provider must determine if they meet certain requirements, including having an undetectable viral load (less than 50 copies/mL).
BIKTARVY does not cure HIV-1 or AIDS. HIV-1 is the virus that causes AIDS.
Whether you are new to treatment or replacing your current HIV-1 medicine, ask your healthcare provider if BIKTARVY is right for you.
The 3 powerful medicines in BIKTARVY were designed to attack the virus right away and to work together to lower the amount of HIV in your blood to undetectable levels. According to the U.S. Department of Health and Human Services (DHHS), many patients can get to undetectable in as quickly as 8 to 24 weeks, when taking their treatment as prescribed.
The 3 powerful medicines in BIKTARVY work quickly to fight the virus.
Whether you’re starting treatment or replacing your current HIV-1 treatment, BIKTARVY can help you reach important HIV-1 health goals.
Adults new to treatment:
Three-year clinical studies showed that most patients taking BIKTARVY every day reached and stayed undetectable. Undetectable is when the amount of virus in your blood is below the level that can be measured in a lab test (less than 50 copies/mL).
BIKTARVY can help increase the number of CD4 T-cells in your blood. T-cells are an important part of your immune system because they help your body fight off infections.
Adults replacing their current treatment:
BIKTARVY can help you stay undetectable and maintain your CD4 T-cell count. Before taking BIKTARVY, your healthcare provider must determine that you meet certain requirements.
Starting or replacing your HIV-1 treatment is an important decision. Your healthcare provider should always work with you to decide if changing your medicine makes sense.
BIKTARVY was evaluated in 4 clinical trials, involving more than 2,400 adults living with HIV.
Results showed that BIKTARVY works in a diverse group of adults, regardless of age, sex, race, viral load, or CD4 T-cell count.
*The other treatments were TRIUMEQ® (abacavir, dolutegravir, lamivudine) or DESCOVY® (emtricitabine, tenofovir alafenamide) + TIVICAY® (dolutegravir).
†The continued treatments were TRIUMEQ (abacavir, dolutegravir, lamivudine) or a combination of either EPZICOM® (abacavir, lamivudine) or TRUVADA® (emtricitabine, tenofovir disoproxil fumarate) + atazanavir or darunavir (with cobicistat or ritonavir).
BIKTARVY may cause serious side effects:
Do not take BIKTARVY if you take:
Serious side effects of BIKTARVY may also include:
The most common side effects of BIKTARVY in clinical studies were diarrhea (6%), nausea (6%), and headache (5%). Tell your healthcare provider if you have any side effects that bother you or don’t go away.
Getting to undetectable quickly is an important goal. But continuing to take your treatment and staying undetectable is just as important. The HIV virus can change and evolve, which means there’s a chance you can develop what’s called drug resistance. That’s when the virus mutates, making your treatment no longer effective.
Zero adults new to treatment developed drug resistance to BIKTARVY through 3 years in clinical trials.
When you keep taking BIKTARVY every day, the medicines keep fighting the virus to help prevent drug resistance.
Download the BIKTARVY patient brochure for more information.
GET PATIENT BROCHURE (PDF)Learn how you may be eligible to get help affording your Gilead medication.
GET FINANCIAL SUPPORTBIKTARVY is a complete,
BIKTARVY does not cure
BIKTARVY may cause serious side effects:
Do not take BIKTARVY if you take:
Serious side effects of BIKTARVY may also include:
The most common side effects of BIKTARVY in clinical studies were diarrhea (6%), nausea (6%), and headache (5%). Tell your healthcare provider if you have any side effects that bother you or don’t go away.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑10881‑800‑FDA‑1088.
Please see Important Facts about BIKTARVY, including important warnings. >
By following this link, you are now leaving BIKTARVY.com. This site is not controlled by Gilead Sciences, Inc. Gilead Sciences, Inc. is not responsible for the site's content or your use of the site.